Functional analysis of 5-lipoxygenase promoter repeat variants

Susanna Vikman, Romulo M. Brena, Patrice Armstrong, Jaana Hartiala, Charles B. Stephensen, Hooman Allayee

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Variants of a hexanucleotide repeat polymorphism in the promoter of the 5-lipoxygenase (5-LO) gene have been associated with cardiovascular disease traits in humans, which may be due, at least in part, to differential expression of the at-risk alleles. To more fully characterize these variants, we carried out gene expression and DNA methylation studies in primary leukocytes from healthy individuals carrying various 5-LO promoter alleles. Regardless of genotype, 5-LO and 5-LO -activating protein (FLAP) gene expression was higher in granulocytes compared with monocytes and lymphocytes, whereas leukotriene A4 hydrolase (LTA4H) expression was higher in monocytes. In all three leukocyte populations, 5-LO mRNA levels were positively correlated with those of FLAP and LTA4H, with the highest correlation observed in granulocytes. In lymphocytes, individuals homozygous for the shorter 3 and 4 repeat alleles had between 20-35% higher 5-LO, FLAP and LTA4H expression compared with homozygous carriers of the wild-type 5 repeat allele (P = 0.03-0.0001). DNA methylation analysis of four CpG islands in a 1500 bp region encompassing the 5-LO promoter and the first ∼100 bp of intron 1 revealed relatively low overall DNA methylation across all genotypes and leukocyte populations. However, analysis of the promoter repeats themselves demonstrated that, regardless of cell population, the 4 allele was methylated approximately twice as much as the 3 allele (P < 0.0001). Our results demonstrate that, in lymphocytes, the shorter repeat alleles of the 5-LO promoter lead to higher gene expression, which may be regulated through differential DNA methylation of the CpGs located within these repeats.

Original languageEnglish (US)
Pages (from-to)4521-4529
Number of pages9
JournalHuman Molecular Genetics
Volume18
Issue number23
DOIs
StatePublished - 2009

Fingerprint

Arachidonate 5-Lipoxygenase
Alleles
DNA Methylation
Leukocytes
Lymphocytes
Gene Expression
Granulocytes
Monocytes
5-Lipoxygenase-Activating Proteins
Genotype
Population
CpG Islands
Introns
Cardiovascular Diseases
Messenger RNA
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Vikman, S., Brena, R. M., Armstrong, P., Hartiala, J., Stephensen, C. B., & Allayee, H. (2009). Functional analysis of 5-lipoxygenase promoter repeat variants. Human Molecular Genetics, 18(23), 4521-4529. https://doi.org/10.1093/hmg/ddp414

Functional analysis of 5-lipoxygenase promoter repeat variants. / Vikman, Susanna; Brena, Romulo M.; Armstrong, Patrice; Hartiala, Jaana; Stephensen, Charles B.; Allayee, Hooman.

In: Human Molecular Genetics, Vol. 18, No. 23, 2009, p. 4521-4529.

Research output: Contribution to journalArticle

Vikman, S, Brena, RM, Armstrong, P, Hartiala, J, Stephensen, CB & Allayee, H 2009, 'Functional analysis of 5-lipoxygenase promoter repeat variants', Human Molecular Genetics, vol. 18, no. 23, pp. 4521-4529. https://doi.org/10.1093/hmg/ddp414
Vikman S, Brena RM, Armstrong P, Hartiala J, Stephensen CB, Allayee H. Functional analysis of 5-lipoxygenase promoter repeat variants. Human Molecular Genetics. 2009;18(23):4521-4529. https://doi.org/10.1093/hmg/ddp414
Vikman, Susanna ; Brena, Romulo M. ; Armstrong, Patrice ; Hartiala, Jaana ; Stephensen, Charles B. ; Allayee, Hooman. / Functional analysis of 5-lipoxygenase promoter repeat variants. In: Human Molecular Genetics. 2009 ; Vol. 18, No. 23. pp. 4521-4529.
@article{4204af10ad394e98adeaf3f953e7e10e,
title = "Functional analysis of 5-lipoxygenase promoter repeat variants",
abstract = "Variants of a hexanucleotide repeat polymorphism in the promoter of the 5-lipoxygenase (5-LO) gene have been associated with cardiovascular disease traits in humans, which may be due, at least in part, to differential expression of the at-risk alleles. To more fully characterize these variants, we carried out gene expression and DNA methylation studies in primary leukocytes from healthy individuals carrying various 5-LO promoter alleles. Regardless of genotype, 5-LO and 5-LO -activating protein (FLAP) gene expression was higher in granulocytes compared with monocytes and lymphocytes, whereas leukotriene A4 hydrolase (LTA4H) expression was higher in monocytes. In all three leukocyte populations, 5-LO mRNA levels were positively correlated with those of FLAP and LTA4H, with the highest correlation observed in granulocytes. In lymphocytes, individuals homozygous for the shorter 3 and 4 repeat alleles had between 20-35{\%} higher 5-LO, FLAP and LTA4H expression compared with homozygous carriers of the wild-type 5 repeat allele (P = 0.03-0.0001). DNA methylation analysis of four CpG islands in a 1500 bp region encompassing the 5-LO promoter and the first ∼100 bp of intron 1 revealed relatively low overall DNA methylation across all genotypes and leukocyte populations. However, analysis of the promoter repeats themselves demonstrated that, regardless of cell population, the 4 allele was methylated approximately twice as much as the 3 allele (P < 0.0001). Our results demonstrate that, in lymphocytes, the shorter repeat alleles of the 5-LO promoter lead to higher gene expression, which may be regulated through differential DNA methylation of the CpGs located within these repeats.",
author = "Susanna Vikman and Brena, {Romulo M.} and Patrice Armstrong and Jaana Hartiala and Stephensen, {Charles B.} and Hooman Allayee",
year = "2009",
doi = "10.1093/hmg/ddp414",
language = "English (US)",
volume = "18",
pages = "4521--4529",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "23",

}

TY - JOUR

T1 - Functional analysis of 5-lipoxygenase promoter repeat variants

AU - Vikman, Susanna

AU - Brena, Romulo M.

AU - Armstrong, Patrice

AU - Hartiala, Jaana

AU - Stephensen, Charles B.

AU - Allayee, Hooman

PY - 2009

Y1 - 2009

N2 - Variants of a hexanucleotide repeat polymorphism in the promoter of the 5-lipoxygenase (5-LO) gene have been associated with cardiovascular disease traits in humans, which may be due, at least in part, to differential expression of the at-risk alleles. To more fully characterize these variants, we carried out gene expression and DNA methylation studies in primary leukocytes from healthy individuals carrying various 5-LO promoter alleles. Regardless of genotype, 5-LO and 5-LO -activating protein (FLAP) gene expression was higher in granulocytes compared with monocytes and lymphocytes, whereas leukotriene A4 hydrolase (LTA4H) expression was higher in monocytes. In all three leukocyte populations, 5-LO mRNA levels were positively correlated with those of FLAP and LTA4H, with the highest correlation observed in granulocytes. In lymphocytes, individuals homozygous for the shorter 3 and 4 repeat alleles had between 20-35% higher 5-LO, FLAP and LTA4H expression compared with homozygous carriers of the wild-type 5 repeat allele (P = 0.03-0.0001). DNA methylation analysis of four CpG islands in a 1500 bp region encompassing the 5-LO promoter and the first ∼100 bp of intron 1 revealed relatively low overall DNA methylation across all genotypes and leukocyte populations. However, analysis of the promoter repeats themselves demonstrated that, regardless of cell population, the 4 allele was methylated approximately twice as much as the 3 allele (P < 0.0001). Our results demonstrate that, in lymphocytes, the shorter repeat alleles of the 5-LO promoter lead to higher gene expression, which may be regulated through differential DNA methylation of the CpGs located within these repeats.

AB - Variants of a hexanucleotide repeat polymorphism in the promoter of the 5-lipoxygenase (5-LO) gene have been associated with cardiovascular disease traits in humans, which may be due, at least in part, to differential expression of the at-risk alleles. To more fully characterize these variants, we carried out gene expression and DNA methylation studies in primary leukocytes from healthy individuals carrying various 5-LO promoter alleles. Regardless of genotype, 5-LO and 5-LO -activating protein (FLAP) gene expression was higher in granulocytes compared with monocytes and lymphocytes, whereas leukotriene A4 hydrolase (LTA4H) expression was higher in monocytes. In all three leukocyte populations, 5-LO mRNA levels were positively correlated with those of FLAP and LTA4H, with the highest correlation observed in granulocytes. In lymphocytes, individuals homozygous for the shorter 3 and 4 repeat alleles had between 20-35% higher 5-LO, FLAP and LTA4H expression compared with homozygous carriers of the wild-type 5 repeat allele (P = 0.03-0.0001). DNA methylation analysis of four CpG islands in a 1500 bp region encompassing the 5-LO promoter and the first ∼100 bp of intron 1 revealed relatively low overall DNA methylation across all genotypes and leukocyte populations. However, analysis of the promoter repeats themselves demonstrated that, regardless of cell population, the 4 allele was methylated approximately twice as much as the 3 allele (P < 0.0001). Our results demonstrate that, in lymphocytes, the shorter repeat alleles of the 5-LO promoter lead to higher gene expression, which may be regulated through differential DNA methylation of the CpGs located within these repeats.

UR - http://www.scopus.com/inward/record.url?scp=70449386908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449386908&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddp414

DO - 10.1093/hmg/ddp414

M3 - Article

C2 - 19717473

AN - SCOPUS:70449386908

VL - 18

SP - 4521

EP - 4529

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 23

ER -